News

Prof. Michelle Farkas from the University of Massachusetts Amherst has been awarded a grant by the National Institutes of Health to develop next-generation tools to track and manipulate circadian rhythms in cancer cells.

Researchers say that eliminating old, dysfunctional cells in human fat also alleviates signs of diabetes. This discovery could lead to new treatments for Type 2 diabetes and other metabolic diseases.

COVID-19 saliva testing kits that include a novel preservative can also be used to measure microscopic organisms in the mouth, a Rutgers study found.

A test to measure both T-cell and antibody response to SARS-CoV-2 in a single blood sample has been developed by scientists at Cardiff University.

Researchers have discovered a way to generate functional cells from stem cells that could open new treatment avenues for people with cystic fibrosis who have liver disease.

Researchers at Rutgers University have developed a novel approach for delivering DNA therapeutics that relies on suction.

The amyloid-beta antibody aducanumab was issued a “negative trend vote” by European regulators, announced its developer Biogen in a statement on November 17.

Fear is essential for survival, but must be well regulated to avoid harmful behaviors such as panic attacks or exaggerated risk taking. Scientists have now demonstrated that the brain relies on the body’s feedback to regulate fear in mice.

The placenta from mothers of healthy newborns could one day be used to reduce brain injury in growth-restricted babies, according to research.

Researchers have identified a single amino acid change in a tumor suppressor protein that extends healthy periods while maintaining longevity.